Expert corner - diabetic retinopathy
Diabetic retinopathy (DR) continues to be a challenge both to clinicians and patients. The systemic variables involved, local mediators implicated, and the coexistence of other ocular conditions such as cataract requires careful planning and delivery of treatment. With the advent of antivascular end...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | TNOA Journal of Ophthalmic Science and Research |
| Subjects: | |
| Online Access: | http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2019;volume=57;issue=2;spage=146;epage=151;aulast=Kim |
| Summary: | Diabetic retinopathy (DR) continues to be a challenge both to clinicians and patients. The systemic variables involved, local mediators implicated, and the coexistence of other ocular conditions such as cataract requires careful planning and delivery of treatment. With the advent of antivascular endothelial growth factor agents, there has been a paradigm shift in the management of DR. Nevertheless, other treatment options such as retinal laser therapy, intravitreal steroids, and vitreoretinal surgery are equally important in selected clinical scenarios. We have a stellar panel of experts who are world-renowned experts in the field of DR. For the benefit of our readers, they distill the essence of evidence-based medicine and share their expertise with particular focus on real-world scenarios in DR. |
|---|---|
| ISSN: | 2589-4528 2589-4536 |